Ugonin P facilitates chondrogenic properties in chondrocytes by inhibiting miR-3074-5p production: implications for the treatment of arthritic disorders
International Journal of Biological Sciences · 2025
DOI: 10.7150/ijbs.108789 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Ting-Kuo Chang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mackay Medical College, New Taipei, Taiwan. Hauptthemen laut MEDLINE: MicroRNAs, Chondrocytes, Flavonoids, Chondrogenesis. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Arthritis is a chronic inflammatory disease that causes joint damage, with osteoarthritis (OA) and rheumatoid arthritis (RA) being the most common types. Both conditions are characterized by cartilage degradation due to an imbalance between repair and breakdown processes. Chondrocytes, the key cells in articular cartilage, maintain its structure by producing an extracellular matrix rich in aggrecan and type II collagen (COL2). MicroRNAs (miRNAs), small noncoding RNAs, regulate genes critical for cartilage balance and are involved in the progression and treatment of OA and RA. Recently, herbal medicines have gained attention for arthritis treatment. Ugonin P, a flavonoid from Helminthostachys zeylanica Hook, is known for its antioxidant and anticancer effects, but its role in cartilage homeostasis is unclear. This study explores ugonin P's chondrogenic effects and its molecular mechanisms involving miRNA regulation. Analysis of Gene Expression Omnibus (GEO) data and clinical samples revealed reduced aggrecan and COL2 levels in OA and RA, while miR-3074-5p levels were elevated, suppressing these proteins. Ugonin P, without affecting cell viability, enhanced aggrecan and COL2 production and promoted chondrocyte differentiation by downregulating miR-3074-5p and activating MAPK pathways. These findings suggest ugonin P as a promising therapeutic candidate for arthritis management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Mackay Medical College, New Taipei, Taiwan.
- Division of Spine Surgery, Department of Orthopedic Surgery, MacKay Memorial Hospital, New Taipei, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
- Translational Medicine Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
- Department of Marine Biotechnology and Resources, National Sun Yat-sen University, Kaohsiung, Taiwan.
- Department of Sports Medicine, College of Health Care, China Medical University, Taichung, Taiwan.
Zitieren
APA
Chang, T. K., Ho, T. L., Lin, Y. Y., Thuong, L. H. H., Lai, K. Y., Tsai, C. H., Liaw, C. C., & Tang, C. H. (2025). Ugonin P facilitates chondrogenic properties in chondrocytes by inhibiting miR-3074-5p production: implications for the treatment of arthritic disorders. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.108789
Vancouver
Chang TK, Ho TL, Lin YY, Thuong LHH, Lai KY, Tsai CH, et al. Ugonin P facilitates chondrogenic properties in chondrocytes by inhibiting miR-3074-5p production: implications for the treatment of arthritic disorders. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.108789
BibTeX
@article{Chang2025,
author = {Chang, Ting-Kuo and Ho, Trung-Loc and Lin, Yen-You and Thuong, Le Huynh Hoai and Lai, Kuan-Ying and Tsai, Chun-Hao and Liaw, Chih-Chuang and Tang, Chih-Hsin},
title = {Ugonin P facilitates chondrogenic properties in chondrocytes by inhibiting miR-3074-5p production: implications for the treatment of arthritic disorders},
journal = {International Journal of Biological Sciences},
year = {2025},
doi = {10.7150/ijbs.108789}
}
EUVIMED